Phase IIb Clinical Trials/Phase III Clinical Trials
As you move over to high stakes clinical development, you’ll benefit from an end-to-end suite of services, relentlessly focused on your drug’s approval.
A clinical research partner with experience in over 55 countries
Plan on quality to prevent drug development errors, minimize delays and mitigate risk
A comprehensive suite of services to fulfill any global clinical trial needs
We help you find the most appropriate locations, most qualified investigators and best patient enrollment populations. Our proprietary informatics capability, Xcellerate®, means you can engage investigators more likely to help you meet your patient enrollment goals from the start. Beyond clinical recruitment, we help you optimize cycle time, uncover supply chain needs and better manage your budget.
You’re not looking for just any experts — you want the right team for your study. We provide a seasoned project management team with relevant scientific and therapeutic expertise in your specific study needs. And, our P3 (predictive, proactive, preventative) Operating Platform helps you rest assured that your projects are delivered within time, quality and profitability targets.
Investigator out-of-pocket costs can make up almost half of your total study budget. We have global processes to ensure efficient, timely and accurate invoicing, which helps you stay within +/-3% of your planned budget more than 90% of the time. This mitigates the surprises that can impact your ROI.
With your drug’s future on the line, you need to navigate a global maze of patient populations, practice patterns and regulatory requirements, often also languages and time zones, before the goal of regulatory approval is in sight. It’s challenging and requires a broad range of expert resources. We offer a comprehensive suite of clinical phase IIb / III services to keep your study on track and improve your ROI.